The National Heart, Lung, and Blood Institute awarded a single-award indefinite-delivery contract to Vitalant Research Institute on September 30, 2026, with a ceiling of $10.4 million for the REDS-V Brazil Transfusion Safety Research Program. The contract carries no set-aside designation.
Work is performed in Westlake, Maryland. The IDIQ procures blood collection, processing, testing, and transfusion medicine research services under the Recipient Epidemiology and Donor Evaluation Study-Brazil International Hub, a research and development initiative focused on epidemiological investigation of donor evaluation and recipient outcomes in a medical research context. The contract is priced cost no fee.
The base period runs September 30, 2026 through September 29, 2027, with an ultimate completion date of September 29, 2033. A delivery order issued on the same date as the IDIQ award establishes the base-period effort at the full ceiling value of $10.4 million. Vitalant Research Institute is the research and specialized services division of Vitalant, the nation's largest independent nonprofit blood services provider.